Evidence map›Paper›PMID 18977641›Full record

ArticleInternational journal of antimicrobial agents2009

In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol.

Mary Cloud B Ammons, Loren S Ward, Steve T Fisher, Randall D Wolcott, Garth A James

Open access · greenAbstract read
In one paragraph

Article in International journal of antimicrobial agents, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Multifunctional FePharmaceutics · 2026
    Article
  5. Investigating the Effect of Xylitol onInternational journal of microbiology · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mary Cloud B AmmonsCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717, USA. marycloud.ammons@erc.montana.edu
Loren S Ward
Steve T Fisher
Randall D Wolcott
Garth A James
Montana State University · USSouthwest Regional Wound Care Center · US

Funding

Healing Chronic Wounds by Controlling Microbial BiofilmP20GM078445 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI STEWART, PHILIP S · 2006 to 2009
$2.8M
NIGMS NIH HHS P20 GM078445
6 · The paper itself

Abstract

The medical impact of bacterial biofilms has increased with the recognition of biofilms as a major contributor to chronic wounds such as diabetic foot ulcers, venous leg ulcers and pressure ulcers. Traditional methods of treatment have proven ineffective, therefore this article presents in vitro evidence to support the use of novel antimicrobials in the treatment of Pseudomonas aeruginosa biofilm. An in vitro biofilm model with a clinical isolate of P. aeruginosa was subjected to treatment with either lactoferrin or xylitol alone or in combination. Combined lactoferrin and xylitol treatment disrupted the structure of the P. aeruginosa biofilm and resulted in a >2log reduction in viability. In situ analysis indicated that while xylitol treatment appeared to disrupt the biofilm structure, lactoferrin treatment resulted in a greater than two-fold increase in the number of permeabilised bacterial cells. The findings presented here indicated that combined treatment with lactoferrin and xylitol significantly decreases the viability of established P. aeruginosa biofilms in vitro and that the antimicrobial mechanism of this treatment includes both biofilm structural disruption and permeablisation of bacterial membranes.

Indexed as

Anti-Bacterial AgentsBiofilmsCell Membrane PermeabilityDrug SynergismHumansLactoferrinMicrobial ViabilityPseudomonas aeruginosaPseudomonas InfectionsWound InfectionXylitolAnti-Bacterial AgentsLactoferrinXylitol

Identifiers

PMID18977641
PMCPMC7008006
OpenAlexW2017305946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.